ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Takeda enters $1.04bn deal with Arrowhead Pharmaceuticals pharmaceutical-technology
October 16, 2020Takeda has entered a collaboration and licensing agreement with Arrowhead Pharmaceuticals to develop an investigational drug, ARO-AAT, for the treatment of alpha-1 antitrypsin-associated liver disease (AATLD).
Pharma Sources Insight July 2025
